OssDsign AB OSSD
OMXSTO · Sweden · Health Technology
SEK 3.59+0.04 (+1.13%)
Market closed· · SEK · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · SEK · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Total return, dividends included.
Where the price sits against its 50- and 200-day moving averages.
Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.
The European market has recently shown a lack of direction, with the pan-European STOXX Europe 600 Index experiencing a slight decline as investors weigh geopolitical developments and economic data. Despite this uncertainty, penny stocks remain an intriguing area for investors looking to uncover growth opportunities at lower price points. While the term "penny stocks" may seem outdated, these smaller or newer companies can still offer significant potential when backed by strong financial...
OssDsign AB (FRA:5J6) reports impressive constant currency growth and high gross margins, while outlining strategic priorities to overcome market penetration challenges.
OssDsign (OM:OSSD) is expected to deliver robust revenue growth of 25.1% per year, far exceeding the Swedish market's projected 3.7% annual growth. Despite this top-line momentum, the company remains unprofitable and has not set expectations for reaching profitability within the next three years. However, it has managed to reduce its losses at a rate of 6.3% per year over the past five years. Investors are focused on this balance of strong growth prospects and steady loss reduction, set...
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.